GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:15611079

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Kochupurakkal, BS, Harari, D, Di-Segni, A, Maik-Rachline, G, Lyass, L, Gur, G, Kerber, G, Citri, A, Lavi, S, Eilam, R, Chalifa-Caspi, V, Eshhar, Z, Pikarsky, E, Pinkas-Kramarski, R, Bacus, SS and Yarden, Y (2005) Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J. Biol. Chem. 280:8503-12

Abstract

Four ErbB receptors and multiple growth factors sharing an epidermal growth factor (EGF) motif underlie transmembrane signaling by the ErbB family in development and cancer. Unlike other ErbB proteins, ErbB-2 binds no known EGF-like ligand. To address the existence of a direct ligand for ErbB-2, we applied algorithms based on genomic and cDNA structures to search sequence data bases. These searches reidentified all known EGF-like growth factors including Epigen (EPG), the least characterized ligand, but failed to identify novel factors. The precursor of EPG is a widely expressed transmembrane glycoprotein that undergoes cleavage at two sites to release a soluble EGF-like domain. A recombinant EPG cannot stimulate cells singly expressing ErbB-2, but it acts as a mitogen for cells expressing ErbB-1 and co-expressing ErbB-2 in combination with the other ErbBs. Interestingly, soluble EPG is more mitogenic than EGF, although its binding affinity is 100-fold lower. Our results attribute the anomalous mitogenic power of EPG to evasion of receptor-mediated depletion of ligand molecules, as well as to inefficient receptor ubiquitylation and down-regulation. In conclusion, EPG might represent the last EGF-like growth factor and define a category of low affinity ligands, whose bioactivity differs from the more extensively studied high affinity ligands.

Links

PubMed Online version:10.1074/jbc.M413919200

Keywords

Algorithms; Amino Acid Motifs; Animals; CHO Cells; COS Cells; Cell Line, Tumor; Cell Membrane/metabolism; Cell Proliferation; Cloning, Molecular; Computational Biology; Cricetinae; DNA, Complementary/metabolism; Dose-Response Relationship, Drug; Down-Regulation; Epidermal Growth Factor/chemistry; Epidermal Growth Factor/metabolism; Epidermal Growth Factor/physiology; Exons; Glycoproteins/chemistry; Glycoproteins/metabolism; Growth Substances; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Introns; Ligands; Male; Mice; Mice, Nude; Mitogens/chemistry; Neoplasm Transplantation; Phosphorylation; Phylogeny; Polymerase Chain Reaction; Prostatic Neoplasms/metabolism; Protein Binding; Protein Structure, Tertiary; Rabbits; Receptor, erbB-2/metabolism; Signal Transduction; Time Factors; Tissue Distribution; Ubiquitin/chemistry

public



Cancel